ANNEX I, Commission Implementing Regulation (EU) No 188/2013 of 5 March 2013 approving the active…

In forcesince 5 Mar 2013

[Further details on identity and specification of active substance are provided in the review report.]

Common name, identification numbers | IUPAC name | Purity | Date of approval | Expiration of approval | Specific provisions

Mandipropamid

CAS No 374726-62-2

CIPAC No 783

(RS)-2-(4-chlorophenyl)-N-[3-methoxy-4-(prop-2-ynyloxy)phenethyl]-2-(prop-2-ynyloxy)acetamide |

≥ 930 g/kg

The impurity N-{2-[4-(2-chloro-allyloxy)-3-methoxy-phenyl]-ethyl}-2-(4-chloro-phenyl)-2-prop-2-ynyloxy-acetamide is of toxicological relevance and shall not exceed 0,1 g/kg in the technical material.

1 August 2013 | 31 July 2023 |

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on mandipropamid, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 1 February 2013 shall be taken into account.

Conditions of use shall include risk mitigation measures, where appropriate.

The applicant shall submit confirmatory information as regards the potential for preferential enantiomeric transformation or racemisation of mandipropamid at the soil surface as a result of soil photolysis.

The applicant shall submit to the Commission, the Member States and the Authority that information by 31 July 2015.